Special Issue "Latest National HPV Vaccine Programs and Outcomes in the World"
Deadline for manuscript submissions: closed (30 April 2022) | Viewed by 12165
Interests: cervical cancer; HPV vaccine; screening; cytology; HPV testing; advocacy; education
Interests: cervical cancer; HPV vaccine; advocacy; epidemiology; education
Special Issues, Collections and Topics in MDPI journals
The World Health Organization (WHO) has officially declared the global strategy on the Elimination of Cervical Cancer in November 2020, which focuses on preventing cervical cancer through HPV vaccination, screening precancerous lesions and managing and treating invasive cervical cancer. The strategies include “Ninety percent of girls should be fully vaccinated by 15 years of age, 70% of women should be screened at least twice with a high-performance test by age 45 and 90% of women with precancer or cancer should receive the appropriate care and treatment, including palliative care”. The stances towards achieving the goal seem to vary from country to country, and knowing the status of each country 0r district may accelerate and encourage the efforts to meet these magnificent goals. In addition, I expect that this special issue will play a certain role for the goal.
Dr. Etsuko Miyagi
Dr. Yutaka Ueda
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Cervical cancer
- HPV vaccine
- HPV testing
- National immunization program